132 related articles for article (PubMed ID: 7198191)
1. Antibody-induced degradation of acetylcholine receptor in myasthenia gravis: clinical correlates and pathogenetic significance.
Tronconi BC; Brigonzi A; Fumagalli G; Sher M; Cosi V; Piccolo G; Clementi F
Neurology; 1981 Nov; 31(11):1440-4. PubMed ID: 7198191
[TBL] [Abstract][Full Text] [Related]
2. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.
Ohta M; Itoh M; Hara H; Itoh N; Nishitani H; Hayashi K; Ohta K
Clin Chim Acta; 1991 Sep; 201(3):201-5. PubMed ID: 1756593
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholine receptor antibodies in myasthenia gravis.
Kornfeld P; Nall J; Smith H; Mittag TW; Bender AN; Ambinder EP; Horowitz SH; Papatestas AE; Gross H; Genkins G
Muscle Nerve; 1981; 4(5):413-9. PubMed ID: 6974823
[TBL] [Abstract][Full Text] [Related]
4. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients.
Limburg PC; The TH; Hummel-Tappel E; Oosterhuis HJ
J Neurol Sci; 1983 Mar; 58(3):357-70. PubMed ID: 6842264
[TBL] [Abstract][Full Text] [Related]
5. Antigenic modulation of human myotube acetylcholine receptor by myasthenic sera. Serum titer determines receptor internalization rate.
Tzartos SJ; Sophianos D; Zimmerman K; Starzinski-Powitz A
J Immunol; 1986 May; 136(9):3231-8. PubMed ID: 3958494
[TBL] [Abstract][Full Text] [Related]
6. Antimuscle and antiacetylcholine receptor antibodies in myasthenia gravis.
Penn AS; Schotland DL; Lamme S
Muscle Nerve; 1986 Jun; 9(5):407-15. PubMed ID: 3724787
[TBL] [Abstract][Full Text] [Related]
7. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
8. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
[TBL] [Abstract][Full Text] [Related]
9. [Antibodies in myasthenia gravis].
Eymard B
Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
[TBL] [Abstract][Full Text] [Related]
10. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
[TBL] [Abstract][Full Text] [Related]
11. Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations.
Kuks JB; Oosterhuis HJ; Limburg PC; The TH
J Autoimmun; 1991 Apr; 4(2):197-211. PubMed ID: 1883480
[TBL] [Abstract][Full Text] [Related]
12. Skeletal muscle antibodies in patients with a thymic tumour but without myasthenia gravis.
Gilhus NE; Aarli JA; Janzen RW; Otto HF; Fasske E; Matre R
J Neuroimmunol; 1985 May; 8(2-3):69-78. PubMed ID: 3998123
[TBL] [Abstract][Full Text] [Related]
13. The diagnosis of thymoma in myasthenia gravis.
Aarli JA
Ital J Neurol Sci; 1983 Dec; 4(4):393-7. PubMed ID: 6370907
[TBL] [Abstract][Full Text] [Related]
14. Remarkably increased resistin levels in anti-AChR antibody-positive myasthenia gravis.
Zhang DQ; Wang R; Li T; Li X; Qi Y; Wang J; Yang L
J Neuroimmunol; 2015 Jun; 283():7-10. PubMed ID: 26004149
[TBL] [Abstract][Full Text] [Related]
15. Myasthenia gravis: antibodies to extracellularly exposed antigenic determinants of acetylcholine receptor.
Oda K; Shibasaki H
Neurology; 1986 Oct; 36(10):1374-7. PubMed ID: 2429233
[TBL] [Abstract][Full Text] [Related]
16. Myasthenia gravis: acetylcholine-receptor antibody titres after thymectomy.
Scadding GK; Thomas HC; Havard CW
Br Med J; 1977 Jun; 1(6075):1512. PubMed ID: 871638
[No Abstract] [Full Text] [Related]
17. Different age-related effects of thymectomy in myasthenia gravis: role of thymoma, zinc, thymulin, IL-2 and IL-6.
Mocchegiani E; Giacconi R; Muzzioli M; Gasparini N; Provinciali L; Spazzafumo L; Licastro F
Mech Ageing Dev; 2000 Aug; 117(1-3):79-91. PubMed ID: 10958925
[TBL] [Abstract][Full Text] [Related]
18. Anti-acetylcholine-receptor antibody concentrations after thymectomy in patients with myasthenia gravis.
Seybold ME; Baergen RN; Nave B; Lindstrom JM
Br Med J; 1978 Oct; 2(6144):1051-3. PubMed ID: 709215
[TBL] [Abstract][Full Text] [Related]
19. Detection of thymoma in myasthenia gravis.
Keesey J; Bein M; Mink J; Sample F; Sarti D; Mulder D; Herrmann C; Peter JB
Neurology; 1980 Mar; 30(3):233-9. PubMed ID: 7189022
[TBL] [Abstract][Full Text] [Related]
20. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera.
Tzartos SJ; Sophianos D; Efthimiadis A
J Immunol; 1985 Apr; 134(4):2343-9. PubMed ID: 3973387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
